Brafv600e-mutant Melanoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-05-16
Clinical Trial Update: BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma [Phase 1, Phase 2]
Phase 1/2 trial updates exploring BKM120 in combination with Vemurafenib for BRAFV600E/K-mutant metastatic melanoma has completed with resul…